National pharmacare will reduce access to new medicines for 27 million privately insured Canadians
April 18, 2024 08:43 ET
|
Canadian Health Policy Institute Inc.
Public vv private drug Insurance coverage for new medicines
Waiting for new medicines in Canada, Europe, and the United States: Study finds Americans get better and faster access to innovative drugs
April 11, 2024 10:30 ET
|
Canadian Health Policy Institute Inc.
Americans get better and faster access to innovative medicines compared to Europeans and Canadians.
Access to new medicines in Canada, Europe, and the United States: Study finds less availability and longer waits for Canadian patients
April 11, 2024 10:00 ET
|
Canadian Health Policy Institute Inc.
A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs.
Cost control rationale for pharmacare does not stand up to scrutiny: Canadian Health Policy Institute
March 14, 2024 10:00 ET
|
Canadian Health Policy Institute Inc.
False narrative about the cost of patented medicines is driving single payer Pharmacare issue in Canada.
Canadian Health Policy Institute reports national pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers: evidence counters Hoskins report
September 24, 2019 14:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Constructive public discussion about a national pharmacare program in Canada is hindered by a lack of balance in the reporting of evidence. Several...
US importation is a catastrophic threat to the Canadian drug supply: two new studies advise urgent action from Canada’s federal government
September 24, 2019 08:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Two new studies published in the journal Canadian Health Policy, conclude that the Canadian federal government must act swiftly and preemptively to stop...
Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans
September 11, 2019 09:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug plans. The research, published in the journal...
Empirical evidence supports critics of Patented Medicine Prices Review Board (PMPRB) regulations
August 21, 2019 10:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Canadian Health Policy Institute (CHPI), a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster the...